Prenatal cell‐free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory

BACKGROUND: We evaluated the performance of a cell‐free DNA (cfDNA) prenatal screening assay for trisomies 21, 18, and 13, and sex chromosome aneuploidies (SCAs) among a population of pregnant women that included both those at average and high risk. METHODS: Specimen collection, cfDNA extraction, ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Guy, Carrie, Haji‐Sheikhi, Farnoosh, Rowland, Charles M., Anderson, Ben, Owen, Renius, Lacbawan, Felicitas L., Alagia, Damian P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418367/
https://www.ncbi.nlm.nih.gov/pubmed/30706702
http://dx.doi.org/10.1002/mgg3.545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6418367/
https://www.ncbi.nlm.nih.gov/pubmed/30706702
http://dx.doi.org/10.1002/mgg3.545

Ejemplares similares